Jan-Inge Henter

Jan-Inge Henter is a Senior Professor at Karolinska Institutet's Department of Women's and Children's Health, specializing in Pediatric Oncology and Hematologic Disorders. He leads the Translational Research group in Childhood Cancer and Histiocytic Diseases, focusing on improving survival outcomes for patients with histiocytic disorders like Hemophagocytic Lymphohistiocytosis (HLH) and Langerhans Cell Histiocytosis (LCH). His research bridges clinical and molecular studies, addressing treatment resistance and cytokine storm syndromes.

• Education: MD from Uppsala University (1980), PhD in Pediatrics from Karolinska Institutet (1990).
• Awards: Received multiple honors including the 2023 Grand Silver Medal for his contributions to pediatric oncology and KI leadership.
• Leadership: Former Director of Research & Education at Karolinska University Hospital (2012–2017), President of the Histiocyte Society (2004–2007).
• Research Focus: HLH diagnostics, LCH pathogenesis, and translational therapies like SAMHD1 inhibition in AML. His group also explores immune-related complications of CAR-T cell therapies.
• Grants: Secured funding from the Swedish Childhood Cancer Foundation for projects addressing pediatric oncology and rare diseases.
• Labs/Teams: Leads a multidisciplinary team including postdocs, PhD students, and clinical researchers, collaborating globally on HLH and LCH initiatives.